FDA Investigator Neal D Singletary, PhD

Neal D Singletary, PhD has inspections in 6 countries as of 08 Sep 2023. Neal D Singletary, PhD has collaborated with a combinined 2375 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
208
Last Inspection Date:
08 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Suriname, Peru, Mexico, Argentina
Co-Investigator(s):
Adrianna G Vargo, Alexandra A Carrico, Amanda L Baskin, Amanda N Schaupp, Amina Bashir, Ana P Barido, Andrea D Swingle, Anthony E Keller, RPh, Antonio M Hampton, Ava M Bowman, Azza Talaat, Barbara D Bennett, Benjamin J Smith, Bernard P Heidt, Brandi N Mcgrady, Brian J Davis, Brian M Campbell, Brian P Hendrickson, Bruce, Calvin K Cook, Carr, CDR Kimberly Y Martin, Charles E Frelix, Charles M Spyr, Chelsea J Falkowski, Christian L Witkovskie, Constantin Y Philopoulos, Corrine M Carter, Crystal M Young Lewis, Daniel J Gorski, Danny Tuntevski, Dariusz Galezowski, David A Lum, David A Paterson, David L Duncan, David P Moorhead, David R Heiar, Dawn C Olenjack, Debara R Reese, Deborah K Richardson, Devon M Shoop, Donna K Speer, Downer, Eboni S Funderburk, Ed Gonzalez Vazquez, Edward Oshaughnessy, Edwardstine J Reese, Emest F Bizjak, Emily J Orban, Eric S Pittman, Erin M Miller, Gale L Glinecki, George G Calafactor, Glenn S Quintanilla, Hans T Meyers, Ifueko Osemwota, Jagan Mohanr Parepally, PhD, James A Lane, James N Rench, Jeffrey A Sommers, Jennifer R Johnson, Jennifer S King, John D Jaworski, John N Woodall, Joie A Navarrete, Jonathan T Little, Joseph R Strelnik, Julie A Silberberg, Karl D Hezel, Kathryn G Brown, Kay M Vialpando, Kelley L Clark, Kenneth A Libertoski, Kenneth Nieves, Kimberly A Dux, Kristina Nastovski, Larry K Austin, Lauren E Burke, Lauren E Sexton, Leigh Anne Myers, Linda S Jozefiak, LT Luis O Rodriguez, Makini Cobourne Duval, PhD, Mancia R Walker, Margaret N Persich, Margo Cl Jones, Maria A Ruttell, Mark G Peterson, Marlon K Turner, Martin R Vowell, Matthew J Gretkierewicz, Meisha R Sampson, Meisha Waters, Michelle L Jones, Michelle L Tripp, Misty D Harvey, Muna Algharibeh, Myra K Casey, Natalie A Mickelsen, DVM, Neal D Singletony, Pablo Alcantara, Patricia H Dlugosz, Patrick B Cummings, Patsy J Domingo, Rafeeq A Habeeb, Randy L Elsberry, Rasha Bamieh, Rebecca E Dombrowski, Robert J Vezzetti, Robert M Barbosa, Robert Rodriguez, Rohn R Robertson, Samuel H Chan, PharmD, Sharon L Shane, Siobhan A Gallagher, Sondra R Davis, State Agency, Tammy M Phillips, Tara R Gooen, Tarsha T Mcclendon, Theodore N Sietsema, Thomas C Woods, Thomas J Hudson, Tracey L Siebesma, Travis S Bradley, Troy R Petrillo, Vera M Anderson, Vesa Vuniqi, William G Nelson, William J Foust, William R Brubaker, Xikui Chen (nmi), PhD, Yiyue Zhang (nmi), PhD

Neal D Singletary, PhD's Documents

Publish Date Document Type Title
March, 2002 FDA 483 Pfizer Inc - Form 483, 2002-03-01
April, 2003 EIR Pfizer Inc - EIR, 2003-04-25
April, 2000 FDA 483 Vesta Pharmaceuticals, Inc. - Form 483, 2000-04-12
December, 2001 FDA 483 Response Pfizer Inc - Form 483R, 2001-12-21
April, 2000 FDA 483 Response Vesta Pharmaceuticals, Inc. - Form 483R, 2000-04-21
December, 2001 FDA 483 Pfizer Inc - Form 483, 2001-12-06
December, 2004 FDA 483 George Green Fishin - Form 483, 2004-12-15
November, 2000 FDA 483 Rush & Hebble Co., Inc. - Form 483, 2000-11-30
September, 2003 FDA 483 Infrared Laboratories, LLC - Form 483, 2003-09-25
April, 2000 EIR Vesta Pharmaceuticals, Inc. - EIR, 2000-04-12
March, 2002 FDA 483 Capriole, Inc. - Form 483, 2002-03-15
December, 2001 EIR Pfizer Inc - EIR, 2001-12-06

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more